Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream
Status:
Completed
Trial end date:
2019-03-09
Target enrollment:
Participant gender:
Summary
This trial is a 4-day, randomized study to determine the phototoxic potential of MC2-01 Cream
when topical application to healthy skin is followed by light exposure.
Phase:
Phase 1
Details
Lead Sponsor:
Drug Delivery Solutions Ltd. (part of MC2 Therapeutics) MC2 Therapeutics